World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
84
Citations
32863
World Ranking
1342
National Ranking
691

Eli O. Meltzer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Eli O. Meltzer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 406 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Eli O. Meltzer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Eli O. Meltzer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 84 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Eli O. Meltzer is affiliated with the University of California, Berkeley in the United States. Their research primarily focuses on medicine, with significant contributions in immunology and allergy, physiology, pulmonary and respiratory medicine, otorhinolaryngology, and surgery.

The main topics covered in Meltzer's work include:

  • Allergic Rhinitis and Sensitization
  • Asthma and Respiratory Diseases
  • Respiratory and Cough-Related Research
  • Sinusitis and Nasal Conditions
  • Nasal Surgery and Airway Studies
  • Olfactory and Sensory Function Studies
  • Pediatric Health and Respiratory Diseases

Meltzer has published research in several journals, with frequent publications in:

  • Journal of Allergy and Clinical Immunology
  • Allergy and Asthma Proceedings
  • Allergy Asthma and Clinical Immunology
  • Annals of Allergy Asthma & Immunology
  • Current Medical Research and Opinion

Some of Meltzer's recent papers include:

  • "Prevalence and Burden of Chronic Cough in the United States" (2021), published in The Journal of Allergy and Clinical Immunology In Practice
  • "Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis" (2021), published in Allergy Asthma and Clinical Immunology

Other notable recent publications, where Meltzer may be involved as a co-author or within the relevant research context, are:

  • "Rhinitis 2020: A practice parameter update" (2020), Journal of Allergy and Clinical Immunology
  • "ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy" (2021), Clinical and Translational Allergy
  • "Shifts in allergy practice in a COVID-19 world: Implications of pre-COVID-19 national health care provider and patient surveys of treatments for nasal allergies" (2021), Allergy and Asthma Proceedings

Meltzer has collaborated frequently with various co-authors, including:

  • Dana Wallace
  • Jonathan A. Bernstein
  • Robert S. Zeiger
  • Peter V. Dicpinigaitis
  • Nelson Augusto Rosário Filho

Best Publications

  • Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

    J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg

  • Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

    Jan L. Brożek;Jean Bousquet;Ioana Agache;Arnav Agarwal

  • Rhinosinusitis: Establishing definitions for clinical research and patient care

    Eli O. Meltzer;Daniel L. Hamilos;James A. Hadley;Donald C. Lanza

  • Rhinosinusitis: developing guidance for clinical trials.

    Eli O. Meltzer;Daniel L. Hamilos;James A. Hadley;Donald C. Lanza

  • Burden of allergic rhinitis: Results from the Pediatric Allergies in America survey

    Eli O. Meltzer;Michael S. Blaiss;M. Jennifer Derebery;Todd A. Mahr

  • Quality of life in adults and children with allergic rhinitis.

    Eli O. Meltzer

  • A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma

    Jonathan Corren;William Busse;Eli O. Meltzer;Lyndon Mansfield

  • Detection of Growth Suppression in Children During Treatment With Intranasal Beclomethasone Dipropionate

    David P. Skoner;Gary S. Rachelefsky;Eli O. Meltzer;Paul Chervinsky

  • Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial

    Eli O. Meltzer;Kerstin Malmstrom;Susan Lu;Bruce M. Prenner

  • Rhinitis 2020: A practice parameter update

    Unknown

  • Prevalence of allergic rhinitis in the United States

    Robert A. Nathan;Eli O. Meltzer;John C. Seiner;William Storms

  • A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis

    Warner Carr;Jonathan Bernstein;Phil Lieberman;Eli Meltzer

  • The economic impact of allergic rhinitis and current guidelines for treatment.

    Eli O. Meltzer;Don A. Bukstein

  • Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys.

    Eli O Meltzer;Michael S Blaiss;Robert M Naclerio;Stuart W Stoloff

  • Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo

    Eli O. Meltzer;Claus Bachert;Heribert Staudinger

  • Rhinosinusitis Diagnosis and Management for the Clinician: A Synopsis of Recent Consensus Guidelines

    Eli O. Meltzer;Daniel L. Hamilos

  • MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

    J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski

  • Allergic Rhinitis

    Unknown

  • ICON: chronic rhinosinusitis

    Claus Bachert;Ruby Pawankar;Luo Zhang;Chaweewan Bunnag

  • Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial☆☆☆★★★

    J A Grant;C F Nicodemus;S R Findlay;M M Glovsky

  • Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma

    Jonathan Corren;Alan G. Harris;Donald Aaronson;Wilfred Beaucher

  • Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey.

    Eli O. Meltzer;Robert Nathan;Jennifer Derebery;Paul E. Stang

Frequent Co-Authors

Robert A. Nathan
Robert A. Nathan University of Colorado Colorado Springs
Claus Bachert
Claus Bachert Karolinska Institute
David Price
David Price University of Aberdeen
Robert M. Naclerio
Robert M. Naclerio University of Chicago
Jean Bousquet
Jean Bousquet University of Montpellier
Thomas B. Casale
Thomas B. Casale University of South Florida
Ruby Pawankar
Ruby Pawankar Nippon Medical School
Phil Lieberman
Phil Lieberman University of Tennessee at Knoxville
William W. Busse
William W. Busse University of Wisconsin–Madison

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related nursing degrees can open diverse career opportunities. Many professionals start with an online ADN programs for non nurses, designed to help career changers enter the nursing field efficiently.

Once in nursing, advancing through an accelerated NP program can speed up the path to becoming a nurse practitioner, allowing for specialization in areas such as immunology-related acute care.

Transitioning from general practice to specialized roles, including becoming an acute care nurse practitioner, requires certification. Guidance on this process is well outlined in resources about acute care nurse practitioner certification, which is critical for those aiming to work with immunocompromised or critically ill patients.

Salary expectations vary by location and certification. Understanding the dnp salary across different states can help professionals plan their careers strategically, ensuring their education investment aligns with financial goals.

Best Scientists Citing Eli O. Meltzer

Trending Scientists

Recently Published Articles